» Authors » Simone Hummler

Simone Hummler

Explore the profile of Simone Hummler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 414
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stoll F, Blank A, Mikus G, Czock D, Foerster K, Hermann S, et al.
Clin Pharmacol Drug Dev . 2021 Jul; 11(2):285-290. PMID: 34268908
Hydroxychloroquine as a weak basic compound with two amines is strongly enriched in cell compartments with low pH, suggesting that modification of gastric pH by coadministered proton pump inhibitors might...
2.
Behr J, Prasse A, Kreuter M, Johow J, Rabe K, Bonella F, et al.
Lancet Respir Med . 2021 Apr; 9(5):476-486. PMID: 33798455
Background: Pirfenidone has been shown to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF). However, there are few treatment options for progressive fibrotic interstitial lung diseases (ILDs)) other...
3.
Wessels S, Muley T, Christopoulos P, Meister M, Heinzmann-Groth I, Warth A, et al.
Transl Lung Cancer Res . 2020 Sep; 9(4):1000-1014. PMID: 32953480
Background: Availability of tumor material at baseline and disease progression is increasingly important for patient management in non-small-cell lung cancer (NSCLC), especially for the application of targeted therapies like tyrosine...
4.
Stoll F, Blank A, Mikus G, Czock D, Foerster K, Hermann S, et al.
Trials . 2020 Jul; 21(1):584. PMID: 32600363
Objectives: Primary objective: Evaluation of the effect of the proton pump inhibitor (PPI) pantoprazole on the absorption of hydroxychloroquine (HCQ). Secondary objectives: • Evaluation of the relationship between HCQ concentrations...
5.
Titz C, Hummler S, Schmidt M, Thomas M, Steins M, Wiskemann J
Support Care Cancer . 2018 Feb; 26(8):2725-2736. PMID: 29480444
Purpose: The aim of this work was to evaluate exercise behavior and physical fitness of advanced lung cancer patients shortly after primary diagnosis. Methods: Between November 2013 and December 2016,...
6.
Bahmer T, Kirsten A, Waschki B, Rabe K, Magnussen H, Kirsten D, et al.
BMC Pulm Med . 2017 Jul; 17(1):104. PMID: 28743305
Background: Physical activity (PA) is associated with disease severity in idiopathic pulmonary fibrosis (IPF), but longitudinal studies evaluating its prognostic value and changes over time are lacking. Methods: We measured...
7.
van Manen M, Kreuter M, van den Blink B, Oltmanns U, Palmowski K, Brunnemer E, et al.
ERJ Open Res . 2017 Feb; 3(1). PMID: 28229083
Pulmonary fibrosis greatly impacts patients and their partners. Unmet needs of patients are increasingly acknowledged; the needs of partners often remain unnoticed. Little is known about the best way to...
8.
Nattenmuller J, Wochner R, Muley T, Steins M, Hummler S, Teucher B, et al.
PLoS One . 2017 Jan; 12(1):e0169136. PMID: 28107410
Introduction: Cachexia and sarcopenia are associated with poor outcome and increased chemotherapy-induced toxicity in lung cancer patients. However, the complex interplay of obesity, sarcopenia and cachexia, and its impact on...
9.
Wiskemann J, Hummler S, Diepold C, Keil M, Abel U, Steindorf K, et al.
BMC Cancer . 2016 Jul; 16:499. PMID: 27430336
Background: Patients with advanced stage non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) often experience multidimensional impairments, affecting quality of life during their course of disease. In...
10.
Bahmer T, Kirsten A, Waschki B, Rabe K, Magnussen H, Kirsten D, et al.
Respiration . 2016 Jun; 91(6):497-502. PMID: 27240427
Background: Little is known about the consequences of idiopathic pulmonary fibrosis (IPF) for physical activity (PA). Objectives: We aimed to investigate levels of PA in IPF and to study associations...